Search results for:
zoledronic acid
zoledronic acid
- Restricted Medications Reclast = Outpatient Only (for osteoporosis)
| Drug Name |
Form |
Strength |
Non-Formulary |
Restricted |
TX Sub |
Notes |
| Reclast |
SOLUTION, INTRAVENOUS |
4 mg/5 mL |
|
|
|
|
| Zometa |
SOLUTION, INTRAVENOUS |
5 mg/100 mL |
|
|
|
|
Last updated: May. 22, 2025
- Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
Zometa (hypercalcemia): not restricted.
The following outlines must be followed.
[Packaging: Manufacturer ⇒ Dispense]
[n/a]
NIOSH Table 2B↑
Receiving / Storage / Preparation
Storage / Administration
Trace- yellow bin
[n/a]
NIOSH Table 2B↑
Receiving / Storage / Preparation
Do not prepare if pregnant.
Storage / Administration
Trace- yellow bin